Purpose-Dry eye is not typically considered a toxicity of whole brain radiation (WBRT). We analyzed dry eye syndrome as part of a prospective study of patient-reported outcomes after WBRT.Methods-Patients receiving WBRT to 25-40 Gy were enrolled on a study with dry mouth as the primary endpoint and dry eye syndrome as a secondary endpoint. Patients received 3-dimensional WBRT using opposed lateral fields. Per standard practice, lacrimal glands were not prospectively delineated. Patients completed the Subjective Evaluation of Symptom of Dryness (SESoD, scored 0-4, higher representing worse dry eye symptoms) at baseline, immediately after WBRT (EndRT), one month (1M), three months (3M), and six months. Patients with baseline SESoD ≥3 (moderate dry eye) were excluded. The endpoints analyzed were ≥1 point and ≥2 point increase in SESoD score at 1M. Lacrimal glands were retrospectively delineated with fused MRI's.Results-100 patients were enrolled, 70 were eligible for analysis, and 54 were evaluable at 1M. Median bilateral lacrimal V20Gy was 79%. At 1M, 17 patients (32%) had a ≥1 point increase in SESoD score, and 13 (24%) a ≥2 point increase. Lacrimal doses appeared to be associated with an increase in SESoD score of both ≥1 point (V10Gy: p=0.042, OR 1.09/Gy, V20Gy: p=0.071, OR 1.03/Gy) and ≥2 points (V10Gy: p=0.038, OR 1.15/Gy, V20Gy: p=0.063, OR 1.04/Gy). The proportion with increase in dry eye symptoms at 1M for lacrimal V20Gy ≥79% vs. <79% was